AEON Biopharma (AEON) News Today $0.91 +0.02 (+2.18%) Closing price 04:00 PM EasternExtended Trading$0.89 -0.02 (-2.34%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEON Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711May 23, 2025 | globenewswire.comJost Fischer Purchases 50,000 Shares of AEON Biopharma, Inc. (NASDAQ:AEON) StockMay 22, 2025 | insidertrades.comAEON Biopharma to Present Corporate Overview at Aegis Capital Corp. 2025 Virtual ConferenceMay 21, 2025 | nasdaq.comAEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025May 19, 2025 | globenewswire.comAEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | globenewswire.comAEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing ComplianceApril 25, 2025 | globenewswire.comAEON Biopharma Announces Inducement Awards for New CEO Rob BancroftApril 23, 2025 | nasdaq.comAeon Biopharma appoints Rob Bancroft as CEOApril 21, 2025 | msn.comAEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711April 21, 2025 | globenewswire.comAEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive OfficerApril 21, 2025 | globenewswire.comBotulinum Toxin Market Forecast 2025-2030: Competitive Positioning, Strategies and Market Share AnalysisApril 14, 2025 | uk.finance.yahoo.comMineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1April 1, 2025 | msn.comAEON Biopharma announces leadership change amid growth strategyMarch 29, 2025 | investing.comAEON Biopharma Announces CEO TransitionMarch 27, 2025 | globenewswire.comAEON Biopharma, Inc. Advances Biosimilar Development for ABP-450 with FDA Meeting Planned for 2025March 26, 2025 | nasdaq.comAEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 24, 2025 | globenewswire.comAEON Biopharma, Inc. to Participate in the Leerink Global Healthcare ConferenceMarch 4, 2025 | globenewswire.comAIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last WeekMarch 3, 2025 | msn.comAEON Biopharma (NASDAQ:AEON) Trading Down 40.1% - Here's WhyAEON Biopharma (NASDAQ:AEON) Shares Down 40.1% - Here's What HappenedMarch 1, 2025 | marketbeat.comAEON Biopharma executes reverse stock split to comply with NYSE standardsFebruary 26, 2025 | investing.comAEON Biopharma, Inc. Announces Reverse Stock SplitFebruary 24, 2025 | globenewswire.comAEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing StandardsFebruary 7, 2025 | globenewswire.comKairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's WhyJanuary 22, 2025 | msn.comAEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public OfferingJanuary 7, 2025 | globenewswire.comAEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News SummaryJanuary 6, 2025 | benzinga.comAeon Biopharma prices 40M units at 50c in underwritten public offeringJanuary 6, 2025 | markets.businessinsider.comAEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public OfferingJanuary 6, 2025 | markets.businessinsider.comAEON Biopharma announces share offeringJanuary 6, 2025 | msn.comAEON Biopharma, Inc. Announces Launch of Proposed Public OfferingJanuary 3, 2025 | globenewswire.comAEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 13, 2024 | globenewswire.comKailera Therapeutics Appoints Scott M. Akamine as Chief Legal OfficerNovember 13, 2024 | finance.yahoo.comAEON Biopharma maps FDA path for Botox biosimilarOctober 2, 2024 | investing.comBuy Rating on AEON Biopharma: Strategic FDA Alignment and Positive Long-Term Revenue ProjectionsOctober 2, 2024 | markets.businessinsider.comAEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory MeetingOctober 1, 2024 | markets.businessinsider.comAEON Biopharma, Inc. (AEON) Stock Price, News, Quote & History - Yahoo FinanceAugust 22, 2024 | finance.yahoo.comAEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024August 19, 2024 | globenewswire.comAEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 12, 2024 | globenewswire.comAEON Biopharma (NASDAQ:AEON) Trading Down 11.8%AEON Biopharma (NASDAQ:AEON) Trading Down 11.8%August 1, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Rating Reiterated by HC WainwrightHC Wainwright restated a "buy" rating and issued a $6.00 price target on shares of AEON Biopharma in a research report on Thursday.May 30, 2024 | marketbeat.comAEON Biopharma Cuts 55% Of Workforce, Terminates CFO To Preserve Cash; Stock Up In Pre-marketMay 29, 2024 | markets.businessinsider.comAEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction PlanMay 29, 2024 | globenewswire.comAEON Biopharma, Inc. (NASDAQ:AEON) Expected to Earn FY2028 Earnings of $0.18 Per ShareAEON Biopharma, Inc. (NASDAQ:AEON - Free Report) - Investment analysts at HC Wainwright issued their FY2028 EPS estimates for AEON Biopharma in a report issued on Wednesday, May 15th. HC Wainwright analyst D. Tsao anticipates that the company will earn $0.18 per share for the year. HC WainwrightMay 17, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Price Target Cut to $6.00HC Wainwright dropped their target price on AEON Biopharma from $18.00 to $6.00 and set a "buy" rating on the stock in a research report on Wednesday.May 15, 2024 | marketbeat.comAEON Biopharma, Inc. (AEON)May 15, 2024 | finance.yahoo.comAEON Biopharma Reports First Quarter 2024 Financial ResultsMay 14, 2024 | globenewswire.comAEON Biopharma Provides Update on Development PipelineMay 9, 2024 | globenewswire.comMaintaining Buy on AEON Biopharma: Potential of ABP-450 Despite Phase 2 SetbackMay 7, 2024 | markets.businessinsider.comAEON Biopharma's (AEON) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $18.00 price target on shares of AEON Biopharma in a report on Monday.May 6, 2024 | marketbeat.comNewly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here WhyMay 3, 2024 | msn.comUS Equity Markets Close Higher Friday Following Weak Jobs ReportMay 3, 2024 | finance.yahoo.com Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address AEON Media Mentions By Week AEON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEON News Sentiment▼-1.000.88▲Average Medical News Sentiment AEON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEON Articles This Week▼10▲AEON Articles Average Week Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MDCX News OKUR News ONCY News CLNN News KPTI News LTRN News XLO News FBLG News ESLA News LVTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEON) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
